Asthma trials in Germany

In Germany 32 Also abroad 500

32 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 11 November 2026. Ask the study team whether a trial fits you.

Phase 3Taking people
A Study to Evaluate the Efficacy and Safety of QVM149 (Indacaterol Acetate / Glycopyrronium Bromide / Mometasone Furoate) Versus Salmeterol Xinafoate/Fluticasone Propionate in Children From 12 Years to Less Than 18 Years of Age With Asthma.
Where
Bielefeld, Wesel
Age
12 years to 17 years
People
188 worldwide
Run by
Novartis Pharmaceuticals
See details and how to joinNCT05776927
Phase 3Taking people
A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe Uncontrolled Asthma (SOLAIRIA-1)
Where
Berlin, Deggingen, Essen, Frankfurt, Frankfurt am Main, Freiburg im Breisgau, Leipzig, Luebeck, München, Witten
Age
12 years to 80 years
People
786 worldwide
Run by
Generate Biomedicines
See details and how to joinNCT07276724 · EU 2025-521950-41-00
Phase 1Taking people
A Study to Compare the Relative Potency of Salbutamol Administered Via Metered Dose Inhalers (MDI) Containing Propellants HFA-152a to HFA-134a in Mild Asthmatics Aged 18 to 65 Inclusive
Where
Hanover
Age
18 years to 65 years
People
84 worldwide
Run by
GlaxoSmithKline
See details and how to joinNCT06433921 · EU 2024-511220-14-00
Phase 1Taking people
A Phase 1b, Double-Blind Study to Investigate Safety, Tolerability, Pharmacokinetics, Efficacy, and Pharmacodynamics of Single Dose of ATI-052 in Participants with Mild to Moderate Asthma
Where
Berlin, Luebeck
Age
18 years and over
People
10
Run by
Aclaris Therapeutics Inc.
See details and how to join2025-524987-39-00 · EU 2025-524987-39-00
Phase 2Taking people
A Study to Evaluate Brenipatide Compared With Placebo in Adult Participants With Uncontrolled Moderate to Severe Asthma
Where
Bendorf, Berlin, Essen, Frankfurt, Hamburg, Leipzig, Mainz, Offenbach
Age
18 years to 75 years
People
531 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT07219173
Phase 4Taking people
A Study Evaluating Disease Characteristics and Outcomes in Participants With Asthma in Routine Clinical Practice
Where
Berlin, Bonn, Frankfurt Am Main, Hohenstein-Ernstthal, Munich, Schleswig
Age
6 years and over
People
2,500 worldwide
Run by
Sanofi
See details and how to joinNCT07556159 · EU 2025-524916-13-00
Phase 2Taking people
A Prospective, Randomized, Open-label, Multicentre Study to Compare the Safety of PURETHAL Mites Mixture 50,000 AUeq/mL Rush Up-Dosing Regimen with the Conventional Up-Dosing Regimen in Adult Participants with Allergic House Dust Mite Rhinitis/Rhinoconjunctivitis with or without Asthma.
Where
Duisburg, Stuttgart
Age
18 years to 64 years
People
120 worldwide
Run by
HAL Allergy B.V.
See details and how to join2026-526908-72-00 · EU 2026-526908-72-00
Phase 2Taking people
Study to Evaluate the Safety, Pharmacology and Efficacy of WIN378 in Adults With Moderate or Severe Asthma
Where
Bendorf, Berlin, Darmstadt, Frankfurt am Main, Hanover, Leipzig, Luebeck, Mainz, München, Neu-Isenburg, Wiesbaden
Age
18 years to 75 years
People
600 worldwide
Run by
Windward Bio
See details and how to joinNCT07120503 · EU 2025-521391-58-00
Phase 2Taking people
A Long-term Study of KT-621 Administered Orally to Participants With Asthma Previously Enrolled in a KT-621 Asthma Study
Where
Berlin
Age
18 years and over
People
264 worldwide
Run by
Kymera Therapeutics, Inc.
See details and how to joinNCT07677059
Phase 2Taking people
A Study of KT-621 Administered Orally to Adult Participants With Moderate to Severe Eosinophilic Asthma
Where
Berlin, Leipzig
Age
18 years to 75 years
People
264 worldwide
Run by
Kymera Therapeutics, Inc.
See details and how to joinNCT07323654
Phase 3Not yet taking people in Germany
Safety and Efficacy Comparison Between CHF5993 100/6 12.5µg pMDI to Seretide Evohaler 125/25µg pMDI in Adolescent Subjects With Asthma
Where
Frankfurt Am Main, Goettingen, Jena
Age
12 years to 17 years
People
700 worldwide
Run by
Chiesi Farmaceutici S.p.A.
See details and how to joinNCT07858123 · EU 2024-514248-95-00
Phase 2Not yet taking people in Germany
A Long-term Study of KT-621 Administered Orally to Participants with Asthma Previously Enrolled in a KT-621 Asthma Study
Where
Berlin, Leipzig
Age
18 years and over
People
77 worldwide
Run by
Kymera Therapeutics Inc.
See details and how to join2026-526241-98-00 · EU 2026-526241-98-00
Phase 2Enrolling by invitation
Long-term Safety and Efficacy Evaluation of Lunsekimig (SAR443765) in Adult Participants With Asthma
Where
Bendorf, Berlin, Frankfurt, Leipzig, Mainz
Age
18 years and over
People
900 worldwide
Run by
Sanofi
See details and how to joinNCT06609239 · EU 2025-522896-27-00
No phaseTaking people
Tezspire Cardiac Events PASS
Where
Berlin
Age
12 years to 130 years
People
16,640 worldwide
Run by
AstraZeneca
See details and how to joinNCT06951867
Phase 3Not yet taking people in Germany
International, multicenter, blinded phase III clinical trial to assess the diagnostic efficacy of the skin prick test from ROXALL (SPT-RX) with different allergen extract solutions for in vivo diagnosis of IgE mediated allergies
Where
Berlin-Charlottenburg, Dresden, Göttingen
Age
18 years to 64 years
People
140 worldwide
Run by
ROXALL Medizin GmbH
See details and how to join2025-524676-32-00 · EU 2025-524676-32-00
Phase 2Taking people
A Study of KT-621 Administered Orally to Adult Participants with Moderate to Severe Eosinophilic Asthma
Where
Berlin, Leipzig
Age
18 years and over
People
121 worldwide
Run by
Kymera Therapeutics Inc.
See details and how to join2025-523180-38-00 · EU 2025-523180-38-00
No phaseTaking people
A Non-interventional, Prospective Study With Benralizumab
Where
Ahrensburg, Ansbach, Aschaffenburg, Auerbach, Augsburg, Bad Homburg, Berlin, Cottbus, Darmstadt, Dresden, Düsseldorf, Ehringshausen, Erkelenz, Essen, Flensburg, Frankfurt am Main, Garmisch-Partenkirchen, Halle, Hamburg, Hanover, Heidelberg, Hohenstein-Ernsttahl, Itzehoe, Jena, Leipzig, Loerrach, Lübeck, Lüneburg, Markkleeberg, Mönchengladbach, Neuruppin, Nuremberg, Papenburg, Rostock, Saalfeld, Spardorf, Weißenburg, Wilhelmshaven, Würzburg, Zossen
Age
18 years to 120 years
People
300
Run by
AstraZeneca
See details and how to joinNCT06422078
Phase 2Taking people
A Study to Evaluate Brenipatide Compared with Placebo in Adult Participants with Uncontrolled Moderate to Severe Asthma
Where
Bendorf, Berlin, Essen, Frankfurt am Main, Hamburg, Leipzig, Mainz, Offenbach
Age
18 years to 64 years
People
137 worldwide
Run by
Eli Lilly & Co.
See details and how to join2025-522640-41-00 · EU 2025-522640-41-00
Phase 3Taking people
A Study of Efficacy and Safety of Depemokimab Compared With Placebo in Adults and Adolescents With at Risk Type 2 Asthma
Where
Bendorf, Berlin, Delitzsch, Frankfurt am Main, Leipzig, Mainz
Age
12 years and over
People
456 worldwide
Run by
GlaxoSmithKline
See details and how to joinNCT07456033 · EU 2025-524463-20-00
Phase 3Enrolling by invitation
Efficacy and Safety of Subcutaneous Dupilumab in Participants With Asthma/Asthmatic Wheeze Aged 2 to <6 Years (LIBERTY ASTHMA TREKIDS)
Where
Duesseldorf, Frankfurt Am Main, Leipzig
Age
2 years to 5 years
People
90 worldwide
Run by
Sanofi
See details and how to joinNCT06191315 · EU 2023-504331-41-00
Phase 3Taking people
A double-dummy, double-blind, randomized, active controlled, two-way cross-over study with 12-week treatment duration per period, to evaluate the efficacy and safety of QVM149 (indacaterol acetate / glycopyrronium bromide / mometasone furoate) compared to salmeterol xinafoate/fluticasone propionate in children from 12 years to less than 18 years of age with asthma.
Where
Bielefeld, Duesseldorf, Goettingen, Leipzig, Wesel
Age
Up to 17 years
People
68 worldwide
Run by
Novartis Pharma AG
See details and how to join2022-502365-26-00 · EU 2022-502365-26-00
Phase 4Taking people
BETRI-Prospective: Asthma Control in Single Inhaler ICS/LABA/LAMA (87/5/9 pMDI [BDP/FF/GB - 100/6/12.5 μg]) vs Single Inhaler ICS/LABA (200/6 pMDI [BDP/FF - 200/6 μg])
Where
Berlin, Cottbus, Darmstadt, Delitzsch, Hohenstein-Ernstthal, Ibbenbueren, Leipzig, Mainz, Marburg, Munchen, Rüdersdorf, Ulm, Wiesbaden, Witten
Age
18 years and over
People
644 worldwide
Run by
Chiesi Farmaceutici S.p.A.
See details and how to joinNCT07666490 · EU 2025-524289-56-00
Phase 2Taking people
A Clinical Study to Evaluate the Efficacy and Safety of Frevecitinib (KN-002) in Patients With Severe Asthma
Where
Bendorf, Berlin, Delitzsch, Frankfurt, Leipzig, München, Schleswig
Age
18 years to 75 years
People
512 worldwide
Run by
Kinaset Therapeutics Inc
See details and how to joinNCT07532265 · EU 2023-509125-41-00
No phaseTaking people
Development of a Novel Non-invasive Inflammometry Following Allergen Challenge in Patients With Mild Allergic Asthma
Where
Hanover
Age
18 years to 65 years
People
15
Run by
Fraunhofer-Institute of Toxicology and Experimental Medicine
See details and how to joinNCT06317909
Phase 3Taking people
Depemokimab Asthma Imaging and Bronchoscopy Sub-Study
Where
Bonn, Frankfurt, Frankfurt am Main, Freiburg im Breisgau, Heidelberg, Mainz
Age
18 years and over
People
150 worldwide
Run by
GlaxoSmithKline
See details and how to joinNCT06979323 · EU 2024-519976-19-00